| December 15, 2010 |
| biOasis Receives Final Report From The University of British Columbia On The Contract Research Agreement for Support of Alzheimer's Disease Diagnostic |
| biOasis Technologies Inc. (TSX:V BTI) has received the final report detailing results achieved within the Contract Research Agreement (CRA) project with The University of British Columbia (UBC) that was announced by the Company on May 19th, 2009. The purpose of this agreement was to generate additional knowledge and data related to the utility of p97 as a proprietary biomarker for Alzheimer's disease (AD). Previous works by UBC and others showed that serum p97 levels are elevated in Alzheimer's disease patients when compared to unaffected individuals and patients with other CNS neuropathies. |
| Read More... >> |
 |
| December 13, 2010 |
| biOasis Announces Completion of Mass Spectrometry Method Intended to Assist with in vitro Diagnosis of Alzheimer's Disease |
| biOasis Technologies Inc. (TSX:V BTI) announced today the completion of the development and initial testing of a second method to detect levels of a serum protein (p97) that is reported to be associated with Alzheimer's disease (AD). The project, which was initiated and announced in late 2008, was intended to develop a SISCAPA (Stable Isotope Standards and Capture by Anti-Peptide Antibodies) assay capable of detecting and measuring protein levels in human plasma. |
| Read More... >> |
|
| November 29, 2010 |
| biOasis Enters Agreement with National Research Council |
biOasis Technologies Inc. (TSX:V BTI)
announced today that it has commenced a sponsored research agreement with the National Research Council (“NRC”) of Canada. Under the terms of the agreement, the NRC will evaluate the ability of biOasis’ compounds to cross the blood-brain barrier using time-domain in vivo optical imaging. |
| Read More... >> |
|
| November 16, 2010 |
| biOasis announces closing of private placement |
biOasis Technologies Inc. (TSX.V: BTI)
Vancouver, BC – is pleased to announce that it has closed the private placement
announced October 22, 2010. |
| Read More... >> |
|
| October 18, 2010 |
| biOasis Receives Blood-Brain Barrier Research Report from The University of British Columbia |
| biOasis Technologies Inc. (TSX:V BTI) has received a final report detailing results achieved within the Collaborative Research project with The University of British Columbia (UBC) that was announced by the Company on June 2, 2009. |
| Read More... >> |
|
| September 7, 2010 |
| biOasis Presents Research Results on Transcend™ at International Symposium on the Blood-Brain Barrier |
| biOasis Technologies Inc. (TSX:V BTI) is pleased to announce that preclinical data on its proprietary Transcend™ (p97) technology for delivery of drugs into the brain was presented during the 13th International Symposium of the Blood-Brain Barrier, held in Zurich, Switzerland from Sept. 2 - 4, 2010. |
| Read More... >> |
|
| August 16, 2010 |
| Hamza Thindal Capital Corporation is appointed to provide investor relations services for biOasis |
| biOasis Technologies Inc. (TSX:V BTI) is pleased to announce that it has entered into a consulting agreement with Hamza Thindal Capital Corporation Inc. ("Hamza Thindal") for Hamza Thindal to provide investor relations services to the Company. |
| Read More... >> |
|
| August 9, 2010 |
| David T. Howard Appointed Director of biOasis Technologies Inc. |
| biOasis Technologies Inc. (TSX:V BTI) is pleased to announce that David T. Howard has accepted an invitation to join the Board of Directors of the Company. |
| Read More... >> |
|
| May 27, 2010 |
| Former BioMarin and Angiochem Executive Joins the biOasis
Scientific Advisory Board |
| biOasis Technologies Inc. (TSX.V:BTI) is pleased to announce the appointment of Dr. Reinhard Gabathuler to the Scientific Advisor Board (“SAB”) of the company. Dr. Gabathuler joins eminent SAB members. |
| Read More... >> |
|
| April 22, 2010 |
| Management Update
2009-2010 Year in Review |
| biOasis Technologies Inc. (TSX.V: BTI) is pleased to provide an update to shareholders on some of its achievements and advances made during its fiscal year ended February 28th, 2010. |
| Read More... >> |
|
| February 22, 2010 |
| Experienced Global Neuroscience Expert joins Board of Directors of biOasis |
| biOasis Technologies Inc. (BTI) is pleased to announce that Dr. H. Christian Fibiger has been appointed to the Board of Directors of the Company. |
| Read More... >> |
|
| February 8, 2010 |
| Experienced Global Biotech Executive joins biOasis as Executive Vice President |
| biOasis Technologies Inc. (BTI) is pleased to announce that Mr. Hugh MacNaught has accepted the position of Executive Vice President with the Company. |
| Read More... >> |
|
